Shares of Gilead Sciences Inc. slid 4.80% to $97.88 Tuesday, on what proved to be an all-around poor trading session for the ...

Shares of Regeneron Pharmaceuticals Inc. shed 7.47% to $558.52 Tuesday, on what proved to be an all-around grim trading ...

Gilead Sciences Down Nearly 5%, On Track for Largest Percent Decrease Since January 2024 — Data Talk Gilead Sciences, Inc. (GILD) is currently at $97.68, down $5.14 or 4.99% --Would be lowest close ...

After counsel withdrew for some of the plaintiffs in a huge consolidated legal battle between Gilead Sciences and patients ...

Health-care companies fell due to regulatory fears. Shares of biotech firm Gilead Sciences, obesity-drug makers Eli Lilly, and Novo Nordisk were among the biggest losers amid reports that the Trump ...

On April 29, 2025, the U.S. Attorney’s Office for the Southern District of New York (SDNY) announced a $202 million civil False Claims Act ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

Gilead is a vast pharmaceutical multinational. With a $175 billion market capitalisation nothing about the company is going to be small. There's a large HIV treatment arm which gives it a base in ...

Aedas Seattle is a comprehensive design practice focused on the life sciences; with transformative program, buildings, and campuses for the private and institutional pioneers of our research ...

Toggle that plays or pauses the background video.